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RADIODIAGNOSTIC AGENT 
This invention relates to a radiodiagnostic agent use 
ful in the clinical analysis of the gastrointestinal tract. 
More particularly, it relates to a preparation comprising 
a solid insoluble resin bearing technetium 99m which is 
especially useful in the evaluation of gastric emptying 
time. I 
Various techniques for clinically testing the gastroin 
testinal tract for numerous ailments are known in the 
art. Some of these techniques involve the use of radioac 
tivity as a means of scanning the GI. tract. In this re 
gard, technetium 99m is the most commonly used radio 
nuclide in nuclear medicine because of its favorable 
imaging characteristics (gamma energy 140 KeV, half 
life 6.0 hours). . 
Chemically, technetium (Tc) belongs to Group VII B 
of the Periodic Table (along with manganese and rhe 
nium) and is known to exist in valence states ranging 
from +1 to +7. The stable forms of the metal in water 
are the pertechnetate (TcO4-, similar to Mn04") and 
TcO2. Technetium 99m is formed by the beta decay of 
molybdenum 99 and decays to To 99 according to the 
following equation: . ‘ 
Tc 99m is obtained in the pertechnetate form by elution 
with normal saline from a technetium generator 
(“Chemistry of Technetium 99m”, J. Steigman and P. 
Richards, “Seminars in Nuclear _Medicine”, 4, 269 
(1974). 
One of the speci?c techniques for clinically evaluat 
ing gastric emptying time in patients having abnormali 
ties of gastric function comprises administering a per 
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technetate solution to the patient together with a meal ' 
and monitoring its passage through the gastrointestinal 
tract by means of a gamma camera. However, this tech 
nique using, an aqueous solution of Te 99m has two 
drawbacks. First, the radioisotope is absorbed from the 
GI. tract, thereby making the test ‘unreliable, and, se 
condly, the solution does not move at‘the same rate as 
the solid food particles. 
To overcome these difficulties, a sulfur colloid of 
technetium has been employed in the place of the per 
technetate solution (“The Gamma Camera in Clinical 
Evaluation of Gastric Emptying”, A. P. van Dam, Ra 
diology, 110, 155 (1974)). However, this colloidal prepa 
ration is generally unstable and is dif?cult to prepare. 
Therefore, there has been a great need in this ?eld for 
a simple preparation which can be used on the clinical 
level even by relatively inexperienced personnel and 
which gives reliable results quickly and effectively 
without any ancillary problems. ‘ , 7 
Accordingly, one of the objects of the present inven 
tion is to provide a radiodiagnostic agent which can be 
readily and simply prepared for use in clinical‘ evalua 
tions and which overcomes the disadvantages and de? 
ciencies of the prior art as noted above. 
Another object of the invention is to providearadio 
diagnostic agent having a high‘ret‘ention of label and 
which is clinically stable for use in determining gastric 
emptying time reliably and effectively. 11‘ ' l ' ‘ 
These and other objects and advantagesof the inven 
tion will become apparent to those skilled in the art 
from a consideration of the following speci?cation and 
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claims, taken in conjunction with the accompanyin, 
drawings, which showvvarious properties of the diag 
nostic preparation of the invention. 
In accordance with the present invention, it has bee: 
found that a preparation comprising a solid, insolubl 
non-toxic synthetic resin bearing technetium 99m pro 
vides a new and useful radiodiagnostic agent which i 
particularly well suited for the clinical evaluation 0 
gastric emptying time. The technetium 99m-containin1 
resin has been found to be a preparation from whicl 
little if any radioisotope is lost upon suspending tht 
resin in aqueous buffers and gastric and intestinal ?uids 
Thus, this solid form of technetium 99m comprises 2 
convenient preparation which can be readily image: 
externally by the use of a gamma camera. Accordingly 
in addition to use in the clinical evaluation of gastric 
emptying time, the Tc-99m bearing resin of the inven 
tion can be used, for example, in in vivo studies on the 
disintegration of various pharmaceutical dosage form: 
such as pills or capsules when incorporated therein in 
the solid dose form. 
The solid preparation of technetium 99m of the in 
vention is obtained by binding or chelating the isotope 
to an insoluble, non-toxic chemically inert synthetic 
resin. This solid preparation is stable and is very simple 
to prepare, for example, within thirty minutes or less. 
Very little radionuclide is absorbed into the blood 
stream upon administration because of its physical na 
ture. For example, less than 1%, which is almost negli 
gible, of the radionuclide was detected in an experimen 
tal animal (dog) when administered thereto orally. 
Moreover, the preparation of the invention, being in a 
granular form, can be easily handled and readily mixed 
with solid food. Thus, it meets all of the criteria of a safe 
and reliable diagnostic agent which can be used clini 
cally in the ?eld of nuclear medicine. 
The base resin employed is preferably a porous non 
toxic synthetic resin such as “popcom” polystyrene, 
which is a white, brittle, insoluble and highly porous 
resin of irregular shape. Other forms of polystyrene can 
be suitably employed. These include polystyrene pre 
pared by bulk, suspension, solution or emulsion poly 
merization. Copolymers of styrene with suitable co 
polymerizable monomers may also be employed. Other 
polymers that can be prepared in granular form and 
which can bear the polyamine functions discussed 
below can also be used advantageously in the diagnostic 
preparation of the invention. 
Chloromethyl (CHZCI) groups or similar chemical 
binding functions are introduced into the base polymer. 
These functions are then converted to aliphatic poly 
amines by reaction with various amines, such as those 
shown in Table 1 below. The resulting resin is then 
treated with a solution of sodium pertechnetate, favor 
ably at pH 1.5, resulting in the transfer of the techne 
tium from the solution to the resin. The resulting Tc 
bearing resin is then washed with water until the wash 
ings do not show any radioactivity. 
The reaction scheme employed to prepare a polysty 
rene resin bearing Tc 99m is thus as follows: 
, E 
polystyrene 
I 
3 
-continued 
0 c1 ——%R_NH2 H2 polyamine 
II 
chloromethylated 
polystyrene 
., 
Na T004” 
III 
polyamine 
resin 
TABLE 1 
Properties of the resins (lH) obtained by reacting _ 
chloromethylated polystyrene (I_I, % Cl= 13.2) with vanous 
Ul P I 
Analysis of the product III 
Resin No. Pnlyamine % Cl % N 
Illa ethylenediamine 0.07 6.46 
(“en" or EDA) 
lllb diethylenetriamine 0.1 1 8. 1 
(“dien” or DTA) 
Illc lriethylenetetramine 0.08 9.02 
(“tr-len” or TETA) 
lIId pentaethylenetetramine 0.66 8.45 
(“tetren” or PETA) 
The general technique for the synthesis of polysty 
rene with various functions and immobilization with 
substances such as amino acids on the polymer is known 
in the art; for example, note Merri?eld, J. Amer. Chem. 
Soc, 85, 2149 (1963) and Letsinger, J. Amer. Chem. Soc., 
85, 3046 (1963). However, the novel ?nding of the in 
vention is the binding of Tc 99m thereon and the use of 
the resulting preparation in clinical evaluations. 
The following Example is given merely as illustrative 
of the present invention and is not to be considered as 
limiting. ’ 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 represents the uptake of KMn 04 by Polysty 
rene-Polyamine resins. 
FIG. 2 represents the uptake of 99Tc O-4by Polysty 
rene-Polyamine resin. 
FIGS. 3 and 4 represent a determination of gastric 
emptying time. 
EXAMPLE 
Preparation of “popcorn” polystyrene (I) — The 
polymer is prepared by copolymerization of styrene 
with a small amount of divinylbenzene (0.2 per cent). 
The polymerization is carried out at 55° C. in the ab 
sence of air after the addition of a few seeds of the 
polymer and usually requires about 48 hours. After 
washing with organic solvents, the resin is dried and 
reduced to 40-100 mesh size. 
Preparation of chloromethylated polystyrene (II) — 
To a suspension of polystyrene (70.0 g) in 500 m1 chlo 
roform at 0° C., a solution of anhydrous stannic chloride 
(35 ml) in chloromethylmethyl ether (90 ml) is added 
I . 4,115,540 
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over 30 minutes. The mixture is stirred at room temper 
ature for 2 hours and ?ltered. The polymer is washed 
repeatedly with chloroform, dioxane-water, water and 
?nally methanol. After drying at 60° C. under vacuo, 
the polymer (85 g) is found to contain 3.5 meq of chlo 
rine per gram. 
Preparation of the polyamine resins (III) — Four 
polyamines are immobilized on the resin (see Table l) 
by the following procedure: The chloromethylated 
resin beads (II, 10 g) are swelled in 40 ml pyridine and 
20 ml of the polyamine is added. The mixture is heated 
over a boiling water bath for 12 hours or until the analy 
sis of the washed resin shows little unreacted chlorine 
(below 0.5 per cent). The resin is separated by ?ltration 
and washed repeatedly with hot pyridine, water and 
methanol. , 
To demonstrate the abilities of the polyamine resins 
(III) to reduce metals in a high oxidation state (+7) to 
a lower state before immobilization of the metal to the 
polymer matrix, the resins are treated with potassium 
permanganate solutions at various pH values. (Manga 
nese and technetium both belong to Group VII B in the 
Periodic Table. Pertechnetate and permanganate anions 
are known to be similar in many respects.) The resin is 
added to the permanganate solution which is decolor 
ized due to the reducing ability of the resin. Samples are 
taken periodically from the solution and analyzed for 
manganese. The results are shown in FIG. 1 in the 
accompanying drawings. 
The technetium bearing resins can be prepared as 
follows: The polyamine resin is suspended in an aqueous 
solution at pH 1.5 obtained by the addition of dilute 
hydrochloric acid. The required amount of the sodium 
pertechnetate solution is added and the mixture stirred 
for 30 minutes. Samples are taken from the solution 
periodically and analyzed for technetium by counting. 
The results are shown in FIG. 2 in the drawings for two 
resins (111a and I110). The resin is removed by ?ltration 
after 30 minutes and washed three times with water. 
The resin can then be mixed with food for gastric emp 
tying studies. For applications requiring dry resin, it can 
be washed with a low boiling organic solvent such as 
acetone and dried. 
In a typical experiment, 0.5 g of the resin is treated 
with 100 ml of a solution of sodium pertechnetate con 
taining the Tc-99rn as pertechnetate. The results of the 
gastric emptying studies on a human volunteer are 
shown in FIG. 3 in the drawings. The logarithm of the 
counts is plotted as a function of time (minutes). 
FIG. 4 illustrates a test conducted to show that very 
little activity is lost with the preparation of the inven 
tion even in strongly acidic conditions. For instance, 
only about 4% activity was released initially when the 
preparation was washed at pH 1.3, and even this loss in 
activity stopped after about 15 minutes in this strongly 
acidic solution. Lower release percentages are observed 
as the pH approaches neutrality. Thus, it is quite clear 
that the labeled polymer complex of the invention is 
highly stable under the conditions as are found with 
gastric contents. f 
The radiodiagnostic agent of the invention, has been 
tested both in dogs as well as humans for the evaluation 
of gastric emptying, as noted above. Generally, disap 
pearance half times (human) of 40 minutes to 150 min 
utes have been observed. 
Hence, the present invention provides an insoluble 
resin-polyamine-Tc 99m complex which is stable, easy 
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to prepare and gives reliable results when used clini 
cally as a diagnostic agent. 
The invention being thus described, it will be obvious 
that the same may be varied in many ways. Such varia 
tions are not to be regarded as a departure from the 
spirit and scope of the invention, and all such modi?ca 
tions are intended to be included within the scope of the 
following claims. 
We claim: 
1. A method for analyzing the gastrointestinal tract of 
a human being or animal which comprises orally admin 
istering a diagnostic amount of a solid, insoluble non 
toxic synthetic resin bearing a detectable amount of Tc 
99m thereon, and analyzing the number of radioactive 
counts given off by the decay of the To 99m as said resin 
passes through the gastrointestinal tract. 
2. A non-biodegradable radiodiagnostic agent useful 
for analyzing the gastrointestinal tract which comprises 
a solid, insoluble, non-toxic synthetic resin bearing a 
detectable amount of Tc-99m therein, said agent having 
no appreciable loss of Tc-99m to the digestive system. 
3. The non-biodegradable radiodiagnostic agent of 
claim 2, wherein the synthetic resin is polystyrene con 
taining an aliphatic polyamine to which the Tc-99m is 
chemically bound. 
4. The non-biodegradable radiodiagnostic agent of 
claim 2, wherein said aliphatic polyamine is ethylenedi 
amine, diethylenetriamine, triethylenetetrarnine or pen 
taethylenetetramine. 
25 
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5. The non-biodegradable radiodiagnostic agent of . 
claim 2, wherein the synthetic resin is a polyacrylate 
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containing COOH, OH, or NH; functions for chemi 
cally bonding the Tc-99m thereto. 
6. The non-biodegradable radiodiagnostic agent of 
claim 5, wherein the polyacrylate is hydroxymethylme 
thacrylate polymer. 
7. The non-biodegradable radiodiagnostic agent of 
claim 2, wherein the synthetic resin is chemically bound 
to Tc-99 m by a member selected from the group con 
sisting of diethylenetriaminepentacetic acid (DTPA), 
iminodiacetic acid, and B-diketones. 
8. A process for the preparation of a radiodiagnostic 
agent which comprises adding phosgene to hydroxyme 
thylmethacrylate polymer followed by the addition of a 
polyamine and then adding an aqueous solution of so 
dium pertechnetate thereto, thereby forming a polya 
mine-Tc-99m complex-containing polyhydroxymethyb 
methacrylate resin. 
9. A process for the preparation of a radiodiagnostic 
agent which comprises mixing chloromethylated poly 
styrene with an organic swelling agent and then further 
adding an aliphatic polyamine thereto, heating the mix 
ture until a polyamine-containing resin is obtained, sus 
pending said polyamine-containing resin in an aqueous 
acidic solution, and then adding an aqueous solution of 
sodium pertechnetate thereto, thereby forming a polya 
mine-Tc 99m complex-containing polystyrene resin. 
10. The process of claim 9, wherein said aliphatic 
polyamine is ethylenediamine, diethylenetriamine, tri 
ethylenetetramine or pentaethylenetetran'iine. 
11. The process of claim 10, wherein said organic 
swelling agent is pyridine. 
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